Veru Inc. is an oncology and urology biopharmaceutical company developing and commercializing novel medicines for the prostate cancer continuum of care and urology specialty pharmaceuticals.
February 12, 2020
Listen to other presentations and conference calls
PARTICIPANT DIAL IN (TOLL FREE): 1-800-341-1602
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-902-6706
Please ask to be joined into the Veru Inc call.
October 2, 2019
Watch the replay of the webcast of our presentation at the 2019 Cantor Fitzgerald Global Healthcare Conference.
(View Slide Deck)
February 26, 2020
Veru Initiates Phase 2 Clinical Trial of VERU-111, First-in-Class, Oral, Advanced Prostate Cancer Drug
Veru Continues Strong Positive Sales Momentum in Fiscal 2020 First Quarter; Net Revenues Increase 66%, Gross Profit Up 57%